Dr. Séverine Bézie, France
MHC-deficient CD8+ Tregs as a universally compatible cell therapy

Dr. Takayuki Hirose, United States
Selective Bcl-2 inhibition promotes hematopoietic chimerism and allograft tolerance without myelosuppressive complications

Mr. Gwangmin Lee, Korea
Anti-C4d chimeric antigen receptor regulatory T cells suppressed allograft rejection in ABO-incompatible heart transplantation

Dr. Hisashi Hashimoto, United Kingdom
Mitochondrial complex V inhibition enhances human regulatory T cell suppressive function through the induction of immunosuppressive small extracellular vesicles

Dr. Girdhari Lal, India
Anti-CD40L antibody promotes the differentiation of Vy2+ regulatory gamma-delta T cells and prolongs the survival of skin allografts.

Dr. Daniel L Eisenson, United States
Tolerance of allogeneic kidneys with durable (>365 days) multilineage chimerism and bone marrow engraftment in cynomolgus macaques